Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester.
Reynoso
E E
EE
Department of Hematology, Instituto Nacional de Cancerologia, Tlalpan, Mexico.
Huerta
F
F
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D005313:Fetal Death / Q000209:etiology*; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage* / Q000009:adverse effects; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011262:Pregnancy Trimester, Second; D012074:Remission Induction
D015255:Idarubicin